F
Frederick W. Reimherr
Researcher at University of Utah
Publications - 124
Citations - 10663
Frederick W. Reimherr is an academic researcher from University of Utah. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Placebo. The author has an hindex of 55, co-authored 123 publications receiving 10228 citations.
Papers
More filters
Journal ArticleDOI
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.
TL;DR: The WURS is sensitive in identifying childhood attention deficit hyperactivity disorder and may be useful in recognizing attention deficithyperactivity disorder in patients with ambiguous adult psychopathology.
Journal ArticleDOI
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Robert Freedman,Hilary Coon,Marina Myles-Worsley,Avi Orr-Urtreger,Ann Olincy,Ashley Davis,Mihael H. Polymeropoulos,John Holik,Jan Hopkins,Mark Hoff,Judy Rosenthal,Merilyne Waldo,Frederick W. Reimherr,Paul H. Wender,J. Yaw,David A. Young,Charles R. Breese,Catherine E. Adams,David Patterson,Lawrence E. Adler,Leonid Kruglyak,Sherry Leonard,William Byerley +22 more
TL;DR: Linkage data provide unique new evidence that the alpha 7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Journal ArticleDOI
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.
David Michelson,Lenard A. Adler,Thomas J. Spencer,Frederick W. Reimherr,Scott A. West,Albert J. Allen,Douglas Kelsey,Joachim F. Wernicke,Anthony Dietrich,Denái R. Milton +9 more
TL;DR: Atomoxetine appears to be an efficacious treatment for adult ADHD, and its lack of abuse potential may be an advantage for many patients.
Journal ArticleDOI
Attention Deficit Disorder ('Minimal Brain Dysfunction') in Adults: A Replication Study of Diagnosis and Drug Treatment
TL;DR: Pemoline was demonstrably more effective than placebo in a random-assignment, parallel, double-blind trial of placebo and pemoline, a noneuphorigenic psychostimulant drug effective in children with ADD.
Journal ArticleDOI
Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report.
TL;DR: To test the hypothesis that MBD does persist into adulthood, 15 putative MBD adults were identified on the basis of current MBD-like complaints, self-description of MBD characteristics in childhood, and a parental rating of "hyperactivity" in childhood.